Appeal No. 1998-0143 Application No. 08/268,177 Claims 11 and 12 are illustrative: 11. A method for eliciting neural fiber growth within the central nervous system which comprises: gaining access to the central nervous system of a patient; providing a microsphere comprising an effective neural fiber growth amount of neuro-active agent encapsulated within a polymer sufficient to elicit neural fiber growth, said polymer (1) being permeable to the neuro- active agent, (2) being biocompatible with the tissues of the central nervous system, (3) being biodegradable within the tissues of the central nervous system without producing toxic byproducts of degradation, and (4) having kinetic characteristics that may be manipulated to allow for the permeation of the neuro-active agent through the polymer at a controlled rate and a predetermined period of time; and implanting said microsphere into the central nervous system of the patient. 12. A method for delivering a pharmaceutically-active agent directly into astrocyte cells of the nervous system which comprises (A) gaining access to the central nervous system of a patient; (B) implanting microspheres of an encapsulated pharmaceutically- active agent in a therapeutically effective amount within the presence of astrocyte cells within the central nervous system of a patient, wherein the microspheres have a diameter of less than about 45 :m and comprise a polymer, said polymer (1) being permeable to the pharmaceutically-active agent, (2) being biocompatible with the tissues of the central nervous system, and (3) having kinetic characteristics that may be manipulated to allow for the permeation of the pharmaceutically-active agent through the polymer at a controlled rate and a predetermined period of time. ISSUES Claims 11-15 stand rejected under 35 U.S.C. § 112, sixth paragraph, as failing to adequately express a means or step for performing a specified function without recital of structure, material, or acts in support thereof. Claims 11-15 stand rejected under the - 2 -Page: Previous 1 2 3 4 5 6 7 8 9 NextLast modified: November 3, 2007